Open tender · Germany · Cn Standard
Open House Originale Rabattverträge 2025-22 - Aclidiniumbromid
The work
Closing discount contracts for the drug Aclidiniumbromid under the Open-House-Originale procedure.
- Must be a pharmaceutical entrepreneur with a valid marketing authorization for Aclidiniumbromid.
- Must be based in the EU/EEA.
- Must not have exclusion grounds under German competition law.
Key facts
- Contract period
- Maximum 24 months starting from 01.10.2025.
What it takes to qualify
Worth a closer look
- The tender document is in German and appears to be for a German entity (TK). The schema is for an Indian government tender. This mismatch may lead to incorrect field mapping.
- The submission mechanics, financial commitments (EMD, tender fee), and evaluation method are not detailed in the provided excerpts.
Experience
- At least 1 similar work — Experience as a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) for the specific drug Aclidiniumbromid.
- Being a pharmaceutical entrepreneur for the drug Aclidiniumbromid.
Certifications and registrations
Valid marketing authorization for AclidiniumbromidMust have a valid Zulassung for the drug according to § 21 AMG.
GST registration (optional)No mention of GST registration in the provided text.
PAN registration (optional)No mention of PAN registration in the provided text.
EPF registration (optional)No mention of EPF registration in the provided text.
ESIC registration (optional)No mention of ESIC registration in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zur Zulassung und zum Unternehmen (Anlage 4 zum Vertrag)Self-declaration of being a pharmaceutical entrepreneur, having a valid marketing authorization, and no legal issues.